Global mRNA Therapeutics Market By Type (Prophylactic Vaccines and Therapeutic Vaccines), By Application (Oncology, Infectious Diseases, Respiratory Diseases, and Others), By End-user (Hospitals & Clinics, Research Organizations, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Oct 2024
Report ID: 131238
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key mRNA Therapeutics Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of mRNA Therapeutics Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global mRNA Therapeutics Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 3.3. Global mRNA Therapeutics Market Attractiveness Analysis, By Type
    3.3.1. Prophylactic Vaccines
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Therapeutic Vaccines
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
  - 3.4. Global mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 3.5. Global mRNA Therapeutics Market Attractiveness Analysis, By Application
    3.5.1. Oncology
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Infectious Diseases
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Respiratory Diseases
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
    3.5.4. Others
    3.5.4.1. Insights
    3.5.4.2. Key Takeaways
  - 3.6. Global mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 3.7. Global mRNA Therapeutics Market Attractiveness Analysis, By End-user
    3.7.1. Hospitals & Clinics
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Research Organizations
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Others
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
- 4. Global mRNA Therapeutics Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global mRNA Therapeutics Market Attractiveness Analysis, By Region
- 5. North America mRNA Therapeutics Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 5.3. North America mRNA Therapeutics Market Attractiveness Analysis, By Type
  - 5.4. North America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 5.5. North America mRNA Therapeutics Market Attractiveness Analysis, By Application
  - 5.6. North America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 5.7. North America mRNA Therapeutics Market Attractiveness Analysis, By End-user
  - 5.8. North America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.9. North America mRNA Therapeutics Market Attractiveness Analysis, By Country
    5.9.1. The US
    5.9.2. Canada
- 6. Europe mRNA Therapeutics Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 6.3. Europe mRNA Therapeutics Market Attractiveness Analysis, By Type
  - 6.4. Europe mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 6.5. Europe mRNA Therapeutics Market Attractiveness Analysis, By Application
  - 6.6. Europe mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 6.7. Europe mRNA Therapeutics Market Attractiveness Analysis, By End-user
  - 6.8. Europe mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.9. Europe mRNA Therapeutics Market Attractiveness Analysis, By Country
    6.9.1. Germany
    6.9.2. The UK
    6.9.3. France
    6.9.4. Spain
    6.9.5. Italy
    6.9.6. Russia
    6.9.7. Netherland
    6.9.8. Rest of Europe
- 7. Asia Pacific mRNA Therapeutics Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 7.3. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Type
  - 7.4. Asia Pacific mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 7.5. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 7.7. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By End-user
  - 7.8. Asia Pacific mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.9. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Country
    7.9.1. China
    7.9.2. Japan
    7.9.3. South Korea
    7.9.4. India
    7.9.5. Australia
    7.9.6. New Zealand
    7.9.7. Singapore
    7.9.8. Thailand
    7.9.9. Vietnam
    7.9.10. Rest of Asia Pacific
- 8. Latin America mRNA Therapeutics Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 8.3. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Type
  - 8.4. Latin America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 8.5. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Application
  - 8.6. Latin America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 8.7. Latin America mRNA Therapeutics Market Attractiveness Analysis, By End-user
  - 8.8. Latin America mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.9. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Country
    8.9.1. Brazil
    8.9.2. Mexico
    8.9.3. Rest of Latin America
  - 9. Middle East & Africa mRNA Therapeutics Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 9.3. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Type
  - 9.4. Middle East & Africa mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 9.5. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2019-2033
  - 9.7. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By End-user
  - 9.8. Middle East & Africa mRNA Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.9. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Country
    9.9.1. South Africa
    9.9.2. Saudi Arabia
    9.9.3. UAE
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Moderna, Inc.
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Ethris GMBH
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Etherna Immunotherapies
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Curevac AG
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. CSL Limited
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. CRISPR Therapeutics AG
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. BioNTech SE
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. AstraZeneca plc.
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Argos Therapeutics Inc.
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Arcturus Therapeutics
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 2. Global mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 3. Global mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 4. Global mRNA Therapeutics Market Value (US$ Mn), By Region, 2019-2033
- Table 5. North America mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 6. North America mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 7. North America mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 8. North America mRNA Therapeutics Market Value (US$ Mn), By Country, 2019-2033
- Table 9. The US mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 10. The US mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 11. The US mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 12. Canada mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 13. Canada mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 14. Canada mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 15. Europe mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 16. Europe mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 17. Europe mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 18. Europe mRNA Therapeutics Market Value (US$ Mn), By Country, 2019-2033
- Table 19. Germany mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 20. Germany mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 21. Germany mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 22. The UK mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 23. The UK mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 24. The UK mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 25. France mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 26. France mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 27. France mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 28. Spain mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 29. Spain mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 30. Spain mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 31. Italy mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 32. Italy mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 33. Italy mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 34. Russia mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 35. Russia mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 36. Russia mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 37. Netherland mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 38. Netherland mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 39. Netherland mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 40. Rest of Europe mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 41. Rest of Europe mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 42. Rest of Europe mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 43. Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 44. Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 45. Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 46. Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By Country, 2019-2033
- Table 47. China mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 48. China mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 49. China mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 50. India mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 51. India mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 52. India mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 53. Japan mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 54. Japan mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 55. Japan mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 56. South Korea mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 57. South Korea mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 58. South Korea mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 59. Australia mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 60. Australia mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 61. Australia mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 62. New Zealand mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 63. New Zealand mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 64. New Zealand mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 65. Singapore mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 66. Singapore mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 67. Singapore mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 68. Thailand mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 69. Thailand mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 70. Thailand mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 71. Vietnam mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 72. Vietnam mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 73. Vietnam mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 74. Rest of Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 75. Rest of Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 76. Rest of Asia Pacific mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 77. Latin America mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 78. Latin America mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 79. Latin America mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 80. Latin America mRNA Therapeutics Market Value (US$ Mn), By Country, 2019-2033
- Table 81. Brazil mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 82. Brazil mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 83. Brazil mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 84. Mexico mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 85. Mexico mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 86. Mexico mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 87. Rest of Latin America mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 88. Rest of Latin America mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 89. Rest of Latin America mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 90. Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 91. Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 92. Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 93. Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By Country, 2019-2033
- Table 94. South Africa mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 95. South Africa mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 96. South Africa mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 97. Saudi Arabia mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 98. Saudi Arabia mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 99. Saudi Arabia mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 100. UAE mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 101. UAE mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 102. UAE mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
- Table 103. Rest of Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By Type, 2019-2033
- Table 104. Rest of Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By Application, 2019-2033
- Table 105. Rest of Middle East & Africa mRNA Therapeutics Market Value (US$ Mn), By End-user, 2019-2033
List of Figures
- Figure 1. Global mRNA Therapeutics Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in mRNA Therapeutics Market
- Figure 5. Global mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 6. Global mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 7. Global mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 8. Global mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 9. Global mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 10. Global mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 11. Global mRNA Therapeutics Market Analysis, By Region, 2019, 2023 and 2033
- Figure 12. Global mRNA Therapeutics Market Attractiveness Analysis, By Region
- Figure 13. North America mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 14. North America mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 15. North America mRNA Therapeutics Market (US$ Mn), by Prophylactic Vaccines, 2019-2033
- Figure 16. North America mRNA Therapeutics Market (US$ Mn), by Therapeutic Vaccines, 2019-2033
- Figure 17. North America mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 18. North America mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 19. North America mRNA Therapeutics Market (US$ Mn), by Oncology, 2019-2033
- Figure 20. North America mRNA Therapeutics Market (US$ Mn), by Infectious Diseases, 2019-2033
- Figure 21. North America mRNA Therapeutics Market (US$ Mn), by Respiratory Diseases, 2019-2033
- Figure 22. North America mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 23. North America mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 24. North America mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 25. North America mRNA Therapeutics Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 26. North America mRNA Therapeutics Market (US$ Mn), by Research Organizations, 2019-2033
- Figure 27. North America mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 28. North America mRNA Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
- Figure 29. North America mRNA Therapeutics Market Attractiveness Analysis, By Country
- Figure 30. Europe mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 31. Europe mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 32. Europe mRNA Therapeutics Market (US$ Mn), by Prophylactic Vaccines, 2019-2033
- Figure 33. Europe mRNA Therapeutics Market (US$ Mn), by Therapeutic Vaccines, 2019-2033
- Figure 34. Europe mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 35. Europe mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 36. Europe mRNA Therapeutics Market (US$ Mn), by Oncology, 2019-2033
- Figure 37. Europe mRNA Therapeutics Market (US$ Mn), by Infectious Diseases, 2019-2033
- Figure 38. Europe mRNA Therapeutics Market (US$ Mn), by Respiratory Diseases, 2019-2033
- Figure 39. Europe mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 40. Europe mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 41. Europe mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 42. Europe mRNA Therapeutics Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 43. Europe mRNA Therapeutics Market (US$ Mn), by Research Organizations, 2019-2033
- Figure 44. Europe mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 45. Europe mRNA Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
- Figure 46. Europe mRNA Therapeutics Market Attractiveness Analysis, By Country
- Figure 47. Asia Pacific mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 48. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 49. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Prophylactic Vaccines, 2019-2033
- Figure 50. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Therapeutic Vaccines, 2019-2033
- Figure 51. Asia Pacific mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 52. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 53. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Oncology, 2019-2033
- Figure 54. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Infectious Diseases, 2019-2033
- Figure 55. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Respiratory Diseases, 2019-2033
- Figure 56. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 57. Asia Pacific mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 58. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 59. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 60. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Research Organizations, 2019-2033
- Figure 61. Asia Pacific mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 62. Asia Pacific mRNA Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
- Figure 63. Asia Pacific mRNA Therapeutics Market Attractiveness Analysis, By Country
- Figure 64. Latin America mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 65. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 66. Latin America mRNA Therapeutics Market (US$ Mn), by Prophylactic Vaccines, 2019-2033
- Figure 67. Latin America mRNA Therapeutics Market (US$ Mn), by Therapeutic Vaccines, 2019-2033
- Figure 68. Latin America mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 69. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 70. Latin America mRNA Therapeutics Market (US$ Mn), by Oncology, 2019-2033
- Figure 71. Latin America mRNA Therapeutics Market (US$ Mn), by Infectious Diseases, 2019-2033
- Figure 72. Latin America mRNA Therapeutics Market (US$ Mn), by Respiratory Diseases, 2019-2033
- Figure 73. Latin America mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 74. Latin America mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 75. Latin America mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 76. Latin America mRNA Therapeutics Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 77. Latin America mRNA Therapeutics Market (US$ Mn), by Research Organizations, 2019-2033
- Figure 78. Latin America mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 79. Latin America mRNA Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
- Figure 80. Latin America mRNA Therapeutics Market Attractiveness Analysis, By Country
- Figure 81. Middle East & Africa mRNA Therapeutics Market Analysis, By Type, 2019, 2023 and 2033
- Figure 82. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Type
- Figure 83. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Prophylactic Vaccines, 2019-2033
- Figure 84. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Therapeutic Vaccines, 2019-2033
- Figure 85. Middle East & Africa mRNA Therapeutics Market Analysis, By Application, 2019, 2023 and 2033
- Figure 86. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Application
- Figure 87. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Oncology, 2019-2033
- Figure 88. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Infectious Diseases, 2019-2033
- Figure 89. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Respiratory Diseases, 2019-2033
- Figure 90. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 91. Middle East & Africa mRNA Therapeutics Market Analysis, By End-user, 2019, 2023 and 2033
- Figure 92. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By End-user
- Figure 93. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 94. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Research Organizations, 2019-2033
- Figure 95. Middle East & Africa mRNA Therapeutics Market (US$ Mn), by Others, 2019-2033
- Figure 96. Middle East & Africa mRNA Therapeutics Market Analysis, By Country, 2019, 2023 and 2033
- Figure 97. Middle East & Africa mRNA Therapeutics Market Attractiveness Analysis, By Country
- Moderna, Inc.
- Ethris GMBH
- Etherna Immunotherapies
- Curevac AG
- CSL Limited
- CRISPR Therapeutics AG
- BioNTech SE
- AstraZeneca plc.
- Argos Therapeutics Inc.
- Arcturus Therapeutics
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients